We are live on ! Find out more
Neuberger Berman Group

Neuberger Berman Group Portfolio holdings

AUM $131B
1-Year Est. Return 28.36%
This Fund
S&P 500
This Quarter Est. Return
+25.27%
1 Year Est. Return
+28.36%
3 Year Est. Return
+86.21%
5 Year Est. Return
+112.87%
10 Year Est. Return
+467.9%
AUM
$80.5B
AUM Growth
+$14.9B
Cap. Flow
-$1.65B
Cap. Flow %
-2.05%
Top 10 Hldgs %
14.87%
Holding
1,659
New
136
Increased
550
Reduced
732
Closed
126

Sector Composition

Rank Sector Weight
1 Technology 25.81%
2 Financials 13.12%
3 Healthcare 12.53%
4 Consumer Discretionary 10%
5 Industrials 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEO icon
926
NeoGenomics
NEO
$1.81B
$2.85M ﹤0.01%
92,300
+50,300
+120% +$1.39M
RGEN icon
927
Repligen
RGEN
$7.44B
$2.84M ﹤0.01%
23,108
-1,967
-8% -$231K
AXTA icon
928
Axalta
AXTA
$7.01B
$2.82M ﹤0.01%
125,096
-22,103
-15% -$452K
HPQ icon
929
HP
HPQ
$23.5B
$2.81M ﹤0.01%
162,005
-11,110
-6% -$177K
DOO
930
Bombardier Recreational Products
DOO
$4.43B
$2.75M ﹤0.01%
64,785
-27,237
-30% -$815K
BRBR icon
931
BellRing Brands
BRBR
$1.51B
$2.75M ﹤0.01%
138,141
-38,274
-22% -$710K
AMED
932
DELISTED
Amedisys
AMED
$2.75M ﹤0.01%
13,866
+3,805
+38% +$710K
CHTR icon
933
Charter Communications
CHTR
$14.7B
$2.75M ﹤0.01%
5,475
+1,809
+49% +$918K
EVER icon
934
EverQuote
EVER
$886M
$2.73M ﹤0.01%
47,000
-15,000
-24% -$705K
UL icon
935
Unilever
UL
$131B
$2.71M ﹤0.01%
43,972
+11,530
+36% +$689K
APO icon
936
Apollo Global Management
APO
$70.7B
$2.71M ﹤0.01%
54,372
-1,785
-3% -$78.3K
AMAT icon
937
Applied Materials
AMAT
$426B
$2.69M ﹤0.01%
45,011
+14,146
+46% +$763K
CNP icon
938
CALL
CenterPoint Energy
CNP
$29.1B
$2.68M ﹤0.01%
+18,800
New +$324K
SWT
939
DELISTED
Stanley Black & Decker, Inc.
SWT
$2.68M ﹤0.01%
29,904
+22,404
+299% +$1.82M
AGIO icon
940
Agios Pharmaceuticals
AGIO
$2.16B
$2.64M ﹤0.01%
49,391
-1,401
-3% -$64.9K
CE icon
941
Celanese
CE
$5.09B
$2.61M ﹤0.01%
30,336
-2,875
-9% -$240K
IOVA icon
942
Iovance Biotherapeutics
IOVA
$2.23B
$2.61M ﹤0.01%
95,075
+59,975
+171% +$1.97M
BMY.RT
943
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$2.6M ﹤0.01%
726,768
+465,429
+178% +$1.68M
RCM
944
DELISTED
R1 RCM Inc. Common Stock
RCM
$2.59M ﹤0.01%
232,280
-110,412
-32% -$1.14M
DBX icon
945
Dropbox
DBX
$6.81B
$2.57M ﹤0.01%
+118,197
New +$2.5M
EHTH icon
946
eHealth
EHTH
$42.5M
$2.56M ﹤0.01%
25,868
+11,842
+84% +$1.38M
WPC icon
947
W.P. Carey
WPC
$17.1B
$2.56M ﹤0.01%
38,567
-14,105
-27% -$876K
BIIB icon
948
Biogen
BIIB
$29.9B
$2.55M ﹤0.01%
9,620
+3,146
+49% +$946K
HRL icon
949
Hormel Foods
HRL
$13.9B
$2.54M ﹤0.01%
52,831
+4,714
+10% +$225K
ESE icon
950
ESCO Technologies
ESE
$8.49B
$2.54M ﹤0.01%
30,000
+6,000
+25% +$474K

Similar funds

Neuberger Berman Group's Q2 2020 Portfolio in Review

As of Q2 2020, Neuberger Berman Group held 1,659 positions worth $80.5B, up 23% from $65.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Neuberger Berman Group's Q2 2020 filing shows 136 new, 550 increased, 732 reduced and 126 closed positions. Its largest new stake was Biora Therapeutics, Inc. Common Stock: 26,164 shares worth $58.9M. The largest sale was Proofpoint, Inc., an estimated $121M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Neuberger Berman Group's largest Q2 2020 buy was Biora Therapeutics, Inc. Common Stock: 26,164 shares worth $58.9M.
  • Neuberger Berman Group added most to TJX Companies in Q2 2020, an estimated $163M increase.
  • Neuberger Berman Group's biggest Q2 2020 reduction was Proofpoint, Inc., cutting an estimated $121M.
  • Neuberger Berman Group fully exited Allergan plc in Q2 2020, selling an estimated $116M.
  • Neuberger Berman Group's ten largest holdings make up 15% of its $80.5B portfolio in Q2 2020.
  • Neuberger Berman Group opened 136 new positions and closed 126 in Q2 2020.
  • Neuberger Berman Group's portfolio value rose 23% quarter-over-quarter to $80.5B.

Based on Neuberger Berman Group's 13F filing for Q2 2020, filed 13 Aug 2020.